Health and wellness products company USANA Health Sciences (NYSE:USNA) reported Q1 CY2025 results beating Wall Street’s revenue expectations , with sales up 9.7% year on year to $250 million.

SALT LAKE CITY, April 28, 2025 /PRNewswire/ -- USANA Health Sciences, Inc., a global leader in cellular nutrition, announced today that its Celavive Postbiotic Rescue Serum was named as a winner ...

SALT LAKE CITY (AP) — SALT LAKE CITY (AP) — USANA Health Sciences Inc. (USNA) on Tuesday reported earnings of $9.4 million in its first quarter. On a per-share basis, the Salt Lake City-based ...